Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SUL-238 by Gen Ilac ve Saglik Urunleri for Alzheimer's Disease: Likelihood of Approval
SUL-238 is under clinical development by Gen Ilac ve Saglik Urunleri and currently in Phase I for Alzheimer's Disease. According...